期刊文献+

福建地区血清HER-2/neu蛋白参考值的建立及分析

Establishment and Analysis of Reference Value of Her-2/neu Protein in Fujian Province
下载PDF
导出
摘要 目的探索建立福建地区成人血清HER-2/neu蛋白参考值。方法选取2019年12月至2021年6月在我院体检的成人共323名为研究对象,采用直接化学发光法对其血清HER-2/neu蛋白进行测定,并依测定数据统计分析得到该项目的单侧上限95%医学参考值。结果获得血清HER-2/neu蛋白中位数为10.0 ng/mL,男性和女性血清HER-2/neu蛋白中位数均为10.0 ng/mL;血清HER-2/neu蛋白95%医学参考值为15.0 ng/mL,男性为14.9 ng/mL,女性为15.3 ng/mL。按性别及年龄分组进行参考值比较,男性与女性成人血清HER-2/neu蛋白差异无统计学意义(P>0.05);年龄段30岁以下、31~40岁、41~50岁与51~60岁比较,差异有高度显著性(P<0.05)。结论血清HER-2/neu蛋白参考值设定为<15.0 ng/mL较为合适。 Objective To establish the reference value of HER-2/neu protein in adult serum in Fujian Province.Methods A total of 323 adults who underwent physical examination in our hospital from December 2019 to June 2021 were selected as the research objects.Their serum HER-2/neu protein was measured by direct chemiluminescence method,and the unilateral upper limit 95%medical reference value of the project was obtained according to the statistical analysis of the measured data.Results The median of serum HER-2/neu protein was 10.0 ng/mL,and the median of serum HER-2/neu protein in men and women was 10.0 ng/mL;The 95%medical reference value of serum HER-2/neu protein was 15.0 ng/mL,14.9 ng/mL in male and 15.3 ng/mL in female.There was no significant difference in HER-2/neu protein between male and female adults;there are highly significant differences between the age groups of under 30 years old,31-40 years old,41-50 years old and 51-60 years old.Conclusion It is appropriate to set the reference value of serum HER-2/neu protein<15.0 ng/mL.
作者 余鸿 吴贻晨 叶曦蔓 陈勇戎 杨婧 徐翔 YU Hong;WU Yichen;YI Ximan;CHEN Yongrong;YANG Jing;XU Xiang(Institute of forensic science,Fujian Provincial Jinshan Hospital,Fuzhou 350001,China;School of basic medicine,Fujian Medical University,Fuzhou 350122,China;Fujian Key Laboratory of Cardiology,Fuzhou 350001,China;Fujian University of traditional Chinese medicine,Fuzhou 350122,China;Fujian Medical University,Fuzhou 350122,China)
出处 《中国医药指南》 2021年第25期10-12,共3页 Guide of China Medicine
基金 福建医科大学“大学生创新创业训练计划项目”(L21107)。
关键词 乳腺癌 血清HER-2/neu蛋白 化学发光法 Serum HER-2/neu protein Mammary cancer Chemiluminescence method Reference value
  • 相关文献

参考文献6

二级参考文献53

  • 1Carney WP, Neumann R, Lipton A, et al. Potential clinical utility of serum HER-2/neu oncoprotein concentrations in patients with breast cancer [J]. Clin Chem, 2003 , 49(10) : 1579-1598.
  • 2Carney WP, Neumann R, Lipton A, et al. Monitoring the circulating levels of the HER2/neu oncoprotein in breast cancer [ J ].Clin Breast Cancer, 2004, 5(2) : 105-116.
  • 3Esteva FJ, Cheli CD, Fritsche H, et al. Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumabbased therapies [ J]. Breast Cancer Res, 2005, 7 (4) : R436- R443.
  • 4Fehm T, Becker S, Duerr-Stoerzer S, et al. Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status [ J ]. Breast Cancer Res, 2007, 9 (5) : R74.
  • 5Regitnig P, Schippinger W, Lindbauer M, et al. Change of HER- 2/neu status in a subset of distant metastases from breast carcinomas [J]. J Pathol, 2004, 203(4) : 918-926.
  • 6Zidan J, Dashkovsky I, Stayerman C, et al. Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease [J]. Br J Cancer, 2005, 93(5) : 552-556.
  • 7Garoufali A, Kyriakou F, Kountourakis P, et al. Extracellular domain of HER2 : a useful marker for the initial workup and follow-up of HER2-positive breast cancer [J]. J BUON, 2008, 13 (3) : 409-413.
  • 8Fehm T, Jager W, Kraemer S, et al. Changes of serum HER2 status during clinical course of metastatic breast cancer patients [ J]. Anticancer Res, 2004 , 24(6) : 4205-4210.
  • 9Bramwell VH, Doig GS, Tuck AB, et al. Changes over time of extracellular domain of HER2 ( ECD/HER2 ) serum levels have prognostic value in metastatic breast cancer [ J]. Breast Cancer Res Treat, 2009, 114(3) : 503-511.
  • 10Ludovini V, Gori S, Colozza M, et al. Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survival [ J ]. Ann Oncol, 2008, 19(5) : 883-890.

共引文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部